Lampalizumab (Anti-Complement Factor D)
A2535
Product group Antibodies
Overview
- SupplierSelleck Chemicals
- Product NameLampalizumab (Anti-Complement Factor D)
- Delivery Days Customer9
- CertificationResearch Use Only
- Estimated Purity...
- Scientific DescriptionLampalizumab (Anti-Complement Factor D) is a humanised monoclonal antibody targeting complement Factor D in the alternative complement pathway. Lampalizumab binds an exosite and sterically blocks Factor B access to the active site. Lampalizumab can be used for age-related macular degeneration (AMD) research. MW: 145.5 KD.
- Storage Instruction-20°C
- UNSPSC12352203